Back to Journals » Vascular Health and Risk Management » Volume 12

Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders

Total article views   Abstract views HTML views PDF downloads Totals
6,494 Dovepress* 3,136 2,288+ 781 5,424
PubMed Central* 0 1,070 435 1,070
Totals 3,136 3,358 1,216 6,494
*Since 10 November 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar